Membranous nephropathy (MN) is the most common cause of nephrotic syndrome among
adults, which is the leading glomerular disease that recurs after kidney transplantation …

Roughly 3% of patients worldwide with a new diagnosis of type 2 diabetes mellitus (T2DM)
already have an overt nephropathy at diagnosis and about 20–30% of the remaining ones …

In recent decades, several important advances have taken place in the understanding of the
pathogenesis underlying membranous nephropathy (MN) that have sparked renewed …

Anti-PLA2R antibodies (Ab) are a diagnostic and prognostic biomarker in primary
membranous nephropathy (PMN). We assessed the relationship between the levels of anti …

Background The currently recommended dose of rituximab for primary membranous
nephropathy is as high as that for lymphoma. However, the clinical manifestations of …

A Japanese man in his early 70s was referred to our hospital because of massive
proteinuria. Analysis of his kidney biopsy demonstrated glomerular subepithelial immune …

Renal biopsy remains the gold standard for diagnosing membranous nephropathy (MN).
Recent studies have suggested that renal biopsy can be replaced with the serum …

Objectives This study aimed to compare the performance of enzyme-linked immunosorbent
assay (ELISA) and magnetic particle chemiluminescence immunoassay (MP-CLIA) for …

Objective The accurate detection of phospholipase A2 receptor (PLA2R) autoantibody is
crucial in the diagnosis and monitoring of primary membranous nephropathy (pMN). While …

The M-type phospholipase A2 receptor autoreactive antibodies (PLA2R-Ab) represent the
leading cause of primary membranous nephropathy (pMN)[1]. Several studies report …